Patent · US Active

Forms and compositions of a MK2 inhibitor

US10882867B2 · kind B2 · utility

8Cited by

6References

23Claims

0Family size

Assignee

Celgene CAR LLC · BM

Inventors

Jianxin Han · Green Brook, US
Lianfeng Huang · Jalan Pedongkelan, US
Uday Jain · Rahway, US
Ying Li · Millburn, US
John Malona · Brookline, US
Kevin Molter · Summit, US
Chittari Pabba · Slingerlands, US
Alexander L. Ruchelman · Cream Ridge, US
Jean Xu · Hackettstown, US
Daozhong Zou · Bound Brook, US

Key dates

Filing date	Mar 15, 2018
Grant date	Jan 5, 2021
Priority date	—
Expiry date	Mar 15, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/005
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides solid forms of an MK2 inhibitor, compositions thereof, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.